|
2026
|
G/S
|
pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceuti... |
|
|
G/S
|
Pharmaceutical preparations for treating alopecia, Alzheimer's disease, atopic dermatitis, autoim... |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hemat... |
|
|
G/S
|
pharmaceutical preparations;pharmaceutical preparations for the treatment of cancer;pharmaceutica... |
|
|
G/S
|
educational services, namely development and dissemination of educational materials in the field ... |
|
|
G/S
|
Pharmaceutical preparations for treating cancer and oncological disorders; Pharmaceutical prepara... |
|
|
G/S
|
Injectors for medical purposes pre-filled with pharmaceutical preparations for treating cancer, i... |
|
2025
|
G/S
|
Injectors for medical purposes pre-filled with pharmaceutical preparations for treating oncology,... |
|
|
G/S
|
Injectors for medical purposes pre-filled with
pharmaceutical preparations for treating oncology... |
|
|
Invention
|
Apparatuses, systems and methods for plunger-stopper depth measurement in pre-filled syringes.
A... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceuti... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for
the treatment of cancer; pharmaceut... |
|
|
G/S
|
Pharmacy services; online retail pharmacy services; mail order pharmacy services; online retail s... |
|
|
G/S
|
Educational services, namely, providing on-line access to podcasts, videos and educational infor... |
|
|
Invention
|
Synthesis of kras g12c inhibitor compound.
The present disclosure relates to an improved, effici... |
|
|
Invention
|
Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by ... |
|
|
Invention
|
Flt1 binding proteins and methods of use. Provided herein are FLT1 binding proteins, as well as r... |
|
|
Invention
|
Single-chain fab proteins and uses thereof. The present invention relates to the field of protein... |
|
|
Invention
|
Drug delivery device.
A drug delivery device may include a housing having an opening and a drug ... |
|
|
G/S
|
Providing medical information in the field of cardiovascular
conditions, diseases, and disorders... |
|
|
Invention
|
Subcutaneous administration of anti-dll3 agent for treatment of cancer. Provided herein is a meth... |
|
|
Invention
|
Methods of detecting off-target binding of proteins.
The present invention relates to methods of... |
|
|
Invention
|
Macrocyclic compounds as modulators of kras and uses thereof. Disclosed herein are compounds usef... |
|
|
Invention
|
Production of viral stocks. Methods of producing Minute Mouse Virus (MMV) stock are described her... |
|
|
Invention
|
Synthetic processes for pharmaceutically active compounds. A process for making a compound of Com... |
|
|
Invention
|
A cell-based platform for identifying native protein-protein interactions in mammalian display li... |
|
|
Invention
|
Improved antibody production. The present invention relates to methods and cell lines for increas... |
|
|
Invention
|
Methods for treating prostate cancer. The present disclosure relates to the treatment of (a) bioc... |
|
|
Invention
|
Bubble trap system and method. A bubble trap system configured for use with a single use centrifu... |
|
|
Invention
|
Lymphoid cell compositions, systems, and assays. in vitroin vitroin vitro methods of antibody pro... |
|
|
Invention
|
Method for reducing protease activities. The present invention relates to mammalian cells modifie... |
|
|
Invention
|
System and method for assessing transferability of a fill recipe. A method for assessing transfer... |
|
|
Invention
|
Avacopan formulations.
The disclosure provides formulations comprising avocapan and one or more ... |
|
|
Invention
|
Avacopan formulations. The disclosure provides formulations comprising avocapan and one or more m... |
|
|
Invention
|
Method for treating prurigo nodularis. The invention provides a method for treating prurigo nodul... |
|
|
Invention
|
Methods for reducing filter fouling in perfusion cell cultures with recirculating tangential flow... |
|
|
Invention
|
Artificial intelligence (ai) validation dataset generation systems and methods for generating ai ... |
|
|
Invention
|
5-membered core compounds as modulators of werner syndrome recq dna helicase and uses thereof. Di... |
|
|
Invention
|
6-membered core compounds as modulators of werner syndrome recq dna helicase and uses thereof. Di... |
|
|
Invention
|
Sequential digestion of polypeptides for mass spectrometric analysis.
The disclosed methods are ... |
|
|
Invention
|
Engineered imine reductases and methods of use thereof. Disclosed herein are engineered polypepti... |
|
|
Invention
|
Inhbe. INHBEINHBE gene. Methods of using such RNAi constructs to treat or prevent visceral obesit... |
|
|
Invention
|
Oral pharmaceutical compositions comprising a naphthyridine compound. Provided herein are pharmac... |
|
|
Invention
|
Compositions comprising anti-pcsk9 antbodies. Compositions comprising a monomer and a dimer of an... |
|
|
Invention
|
Dosing of kras inhibitor for treatment of cancers.
Provided herein are methods of administering ... |
|
|
Invention
|
Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer.
The present invention p... |
|
|
Invention
|
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibit... |
|
|
Invention
|
Method of conjugation of cys-mabs.
The present disclosure relates to a method of capping, reduci... |
|
2023
|
Invention
|
Multispecific molecules for clearance of immunoglobulins in the treatment of autoantibody-induced... |
|
|
Invention
|
A method for harvesting products from high cell density perfusion cell cultures.
The disclosure ... |
|
|
Invention
|
Bispecific molecule stabilizing composition.
The present invention provides provide a pharmaceut... |
|
|
Invention
|
Optical systems and platforms for simultaneously analyzing multiple solution properties.
Disclos... |
|
|
Invention
|
Predictive model to evaluate processing time impacts.
Systems and methods for evaluating impacts... |
|
|
Invention
|
Anti-drug antibody assays.
The present invention relates methods of detecting anti-drug antibodi... |
|
|
Invention
|
Needle shield assembly for a syringe.
A needle shield assembly includes a first needle shield at... |
|
|
Invention
|
Needle shield for syringe.
A syringe assembly includes a syringe having a barrel and a needle hu... |
|
|
Invention
|
Therapeutic product mixing methods.
Methods for mixing fluids including etanercept include provi... |
|
|
Invention
|
Treatment of erosive hand osteoarthritis.
Provided herein are methods of treating erosive hand o... |
|
|
Invention
|
Methods for treating cancer.
Provided herein are methods of treating cancer comprising a KRAS G1... |
|
|
Invention
|
Magea4 specific t cell receptors.
Provided herein are recombinant T-cell receptors (TCRs) that c... |
|
|
Invention
|
Clearance of aggregates from uf/df pools in downstream antibody purification.
A method for impro... |
|
|
Invention
|
Combination therapy methods with t-cell engaging molecules for treatment of prostate cancer.
The... |
|
2022
|
Invention
|
Sotorasib dosing regimen.
The present disclosure provides method of administering sotorasib to a... |
|
2021
|
Invention
|
Stable cyclodextrin free carfilzomib formulation.
This disclosure provides a stable cyclodextrin... |
